Tani K, Sato Seiichi, Sukezane Taiko, Kojima Hiroshi, Hirose Hidenori, Hanafusa Hidesaburo, Shishido Tomoyuki (June 2003). „Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase”. J. Biol. Chem.278 (24): 21685–92. DOI:10.1074/jbc.M301447200. PMID12672821.
Biesova Z, Piccoli C, Wong W T (January 1997). „Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth”. Oncogene14 (2): 233–41. DOI:10.1038/sj.onc.1200822. PMID9010225.
Yamamoto A, Suzuki T, Sakaki Y (June 2001). „Isolation of hNap1BP which interacts with human Nap1 (NCKAP1) whose expression is down-regulated in Alzheimer's disease”. Gene271 (2): 159–69. DOI:10.1016/S0378-1119(01)00521-2. PMID11418237.
Cao C, Leng Yumei, Li Chufang, Kufe Donald (April 2003). „Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response”. J. Biol. Chem.278 (15): 12961–7. DOI:10.1074/jbc.M300058200. PMID12569093.
Dai Z, Pendergast A M (November 1995). „Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity”. Genes Dev.9 (21): 2569–82. DOI:10.1101/gad.9.21.2569. PMID7590236.
Chen G, Yuan S S, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff S P, Wu Y, Arlinghaus R, Baltimore D, Gasser P J, Park M S, Sung P, Lee E Y (April 1999). „Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl”. J. Biol. Chem.274 (18): 12748–52. DOI:10.1074/jbc.274.18.12748. PMID10212258.
Shafman T, Khanna K K, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin M F (May 1997). „Interaction between ATM protein and c-Abl in response to DNA damage”. Nature387 (6632): 520–3. DOI:10.1038/387520a0. PMID9168117.
Kishi S, Zhou X Z, Ziv Y, Khoo C, Hill D E, Shiloh Y, Lu K P (August 2001). „Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks”. J. Biol. Chem.276 (31): 29282–91. DOI:10.1074/jbc.M011534200. PMID11375976.
Salgia R, Pisick E, Sattler M, Li J L, Uemura N, Wong W K, Burky S A, Hirai H, Chen L B, Griffin J D (October 1996). „p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene”. J. Biol. Chem.271 (41): 25198–203. DOI:10.1074/jbc.271.41.25198. PMID8810278.
Mayer BJ, Hirai H, Sakai R (March 1995). „Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases”. Curr. Biol.5 (3): 296–305. DOI:10.1016/S0960-9822(95)00060-1. PMID7780740.
Pendergast AM, Muller A J, Havlik M H, Maru Y, Witte O N (July 1991). „BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner”. Cell66 (1): 161–71. DOI:10.1016/0092-8674(91)90148-R. PMID1712671.
Cao C, Leng Yumei, Kufe Donald (August 2003). „Catalase activity is regulated by c-Abl and Arg in the oxidative stress response”. J. Biol. Chem.278 (32): 29667–75. DOI:10.1074/jbc.M301292200. PMID12777400.
Miyoshi-Akiyama T, Aleman L M, Smith J M, Adler C E, Mayer B J (July 2001). „Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor”. Oncogene20 (30): 4058–69. DOI:10.1038/sj.onc.1204528. PMID11494134.
Yamanashi Y, Baltimore D (January 1997). „Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok”. Cell88 (2): 205–11. DOI:10.1016/S0092-8674(00)81841-3. PMID9008161.
Yu HH, Zisch A H, Dodelet V C, Pasquale E B (July 2001). „Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor”. Oncogene20 (30): 3995–4006. DOI:10.1038/sj.onc.1204524. PMID11494128.
Cao C, Leng Yumei, Huang Wei, Liu Xuan, Kufe Donald (October 2003). „Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases”. J. Biol. Chem.278 (41): 39609–14. DOI:10.1074/jbc.M305770200. PMID12893824.
Bai RY, Jahn T, Schrem S, Munzert G, Weidner K M, Wang J Y, Duyster J (August 1998). „The SH2-containing adapter protein GRB10 interacts with BCR-ABL”. Oncogene17 (8): 941–8. DOI:10.1038/sj.onc.1202024. PMID9747873.
Frantz JD, Giorgetti-Peraldi S, Ottinger E A, Shoelson S E (January 1997). „Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains”. J. Biol. Chem.272 (5): 2659–67. DOI:10.1074/jbc.272.5.2659. PMID9006901.
Kumar V, Sabatini D, Pandey P, Gingras A C, Majumder P K, Kumar M, Yuan Z M, Carmichael G, Weichselbaum R, Sonenberg N, Kufe D, Kharbanda S (April 2000). „Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase”. J. Biol. Chem.275 (15): 10779–87. DOI:10.1074/jbc.275.15.10779. PMID10753870.
Warmuth M, Bergmann M, Priess A, Häuslmann K, Emmerich B, Hallek M (December 1997). „The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr”. J. Biol. Chem.272 (52): 33260–70. DOI:10.1074/jbc.272.52.33260. PMID9407116.
Koch A, Mancini A, Stefan M, Niedenthal R, Niemann H, Tamura T (March 2000). „Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop”. FEBS Lett.469 (1): 72–6. DOI:10.1016/S0014-5793(00)01242-4. PMID10708759.
Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang Y Y, Lu H, Kharbanda S, Weichselbaum R, Kufe D (June 1999). „p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage”. Nature399 (6738): 814–7. DOI:10.1038/21704. PMID10391251.
Agami R, Blandino G, Oren M, Shaul Y (June 1999). „Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis”. Nature399 (6738): 809–13. DOI:10.1038/21697. PMID10391250.
Cong F, Spencer S, Côté J F, Wu Y, Tremblay M L, Lasky L A, Goff S P (December 2000). „Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation”. Mol. Cell6 (6): 1413–23. DOI:10.1016/S1097-2765(00)00138-6. PMID11163214.
Miyamura T, Nishimura J, Yufu Y, Nawata H (February 1997). „Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines”. Int. J. Hematol.65 (2): 115–21. DOI:10.1016/S0925-5710(96)00539-7. PMID9071815.
Welch PJ, Wang J Y (November 1993). „A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle”. Cell75 (4): 779–90. DOI:10.1016/0092-8674(93)90497-E. PMID8242749.
Agami R, Shaul Y (April 1998). „The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes”. Oncogene16 (14): 1779–88. DOI:10.1038/sj.onc.1201708. PMID9583676.
Wang B, Golemis E A, Kruh G D (July 1997). „ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks”. J. Biol. Chem.272 (28): 17542–50. DOI:10.1074/jbc.272.28.17542. PMID9211900.
Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim K S, Jenkins E C, Trenkner E, Kotula L (May 1998). „Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton”. J. Biol. Chem.273 (22): 13681–92. DOI:10.1074/jbc.273.22.13681. PMID9593709.
Bassermann F, Jahn Thomas, Miething Cornelius, Seipel Petra, Bai Ren-Yuan, Coutinho Sunita, Tybulewicz Victor L, Peschel Christian, Duyster Justus (April 2002). „Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway”. J. Biol. Chem.277 (14): 12437–45. DOI:10.1074/jbc.M112397200. PMID11790798.
Rafalska I, Zhang Zhaiyi, Benderska Natalya, Wolff Horst, Hartmann Annette M, Brack-Werner Ruth, Stamm Stefan (August 2004). „The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation”. Hum. Mol. Genet.13 (15): 1535–49. DOI:10.1093/hmg/ddh167. PMID15175272.
Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M (June 2008). „Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression”. Cancer Cell13 (6): 496–506. DOI:10.1016/j.ccr.2008.04.018. PMID18538733.
Tani K, Sato Seiichi, Sukezane Taiko, Kojima Hiroshi, Hirose Hidenori, Hanafusa Hidesaburo, Shishido Tomoyuki (June 2003). „Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase”. J. Biol. Chem.278 (24): 21685–92. DOI:10.1074/jbc.M301447200. PMID12672821.
Biesova Z, Piccoli C, Wong W T (January 1997). „Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth”. Oncogene14 (2): 233–41. DOI:10.1038/sj.onc.1200822. PMID9010225.
Yamamoto A, Suzuki T, Sakaki Y (June 2001). „Isolation of hNap1BP which interacts with human Nap1 (NCKAP1) whose expression is down-regulated in Alzheimer's disease”. Gene271 (2): 159–69. DOI:10.1016/S0378-1119(01)00521-2. PMID11418237.
Cao C, Leng Yumei, Li Chufang, Kufe Donald (April 2003). „Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response”. J. Biol. Chem.278 (15): 12961–7. DOI:10.1074/jbc.M300058200. PMID12569093.
Dai Z, Pendergast A M (November 1995). „Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity”. Genes Dev.9 (21): 2569–82. DOI:10.1101/gad.9.21.2569. PMID7590236.
Chen G, Yuan S S, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff S P, Wu Y, Arlinghaus R, Baltimore D, Gasser P J, Park M S, Sung P, Lee E Y (April 1999). „Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl”. J. Biol. Chem.274 (18): 12748–52. DOI:10.1074/jbc.274.18.12748. PMID10212258.
Shafman T, Khanna K K, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin M F (May 1997). „Interaction between ATM protein and c-Abl in response to DNA damage”. Nature387 (6632): 520–3. DOI:10.1038/387520a0. PMID9168117.
Kishi S, Zhou X Z, Ziv Y, Khoo C, Hill D E, Shiloh Y, Lu K P (August 2001). „Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks”. J. Biol. Chem.276 (31): 29282–91. DOI:10.1074/jbc.M011534200. PMID11375976.
Salgia R, Pisick E, Sattler M, Li J L, Uemura N, Wong W K, Burky S A, Hirai H, Chen L B, Griffin J D (October 1996). „p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene”. J. Biol. Chem.271 (41): 25198–203. DOI:10.1074/jbc.271.41.25198. PMID8810278.
Mayer BJ, Hirai H, Sakai R (March 1995). „Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases”. Curr. Biol.5 (3): 296–305. DOI:10.1016/S0960-9822(95)00060-1. PMID7780740.
Ling X, Ma Guozhen, Sun Tong, Liu Jiaxin, Arlinghaus Ralph B (January 2003). „Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr”. Cancer Res.63 (2): 298–303. PMID12543778.
Pendergast AM, Muller A J, Havlik M H, Maru Y, Witte O N (July 1991). „BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner”. Cell66 (1): 161–71. DOI:10.1016/0092-8674(91)90148-R. PMID1712671.
Cao C, Leng Yumei, Kufe Donald (August 2003). „Catalase activity is regulated by c-Abl and Arg in the oxidative stress response”. J. Biol. Chem.278 (32): 29667–75. DOI:10.1074/jbc.M301292200. PMID12777400.
Miyoshi-Akiyama T, Aleman L M, Smith J M, Adler C E, Mayer B J (July 2001). „Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor”. Oncogene20 (30): 4058–69. DOI:10.1038/sj.onc.1204528. PMID11494134.
Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker B J (January 1997). „Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation”. Blood89 (1): 297–306. PMID8978305.
Kyono WT, de Jong R, Park R K, Liu Y, Heisterkamp N, Groffen J, Durden D L (November 1998). „Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI)”. J. Immunol.161 (10): 5555–63. PMID9820532.
van Dijk TB, van Den Akker E, Amelsvoort M P, Mano H, Löwenberg B, von Lindern M (November 2000). „Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells”. Blood96 (10): 3406–13. PMID11071635.
Yamanashi Y, Baltimore D (January 1997). „Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok”. Cell88 (2): 205–11. DOI:10.1016/S0092-8674(00)81841-3. PMID9008161.
Yu HH, Zisch A H, Dodelet V C, Pasquale E B (July 2001). „Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor”. Oncogene20 (30): 3995–4006. DOI:10.1038/sj.onc.1204524. PMID11494128.
Cao C, Leng Yumei, Huang Wei, Liu Xuan, Kufe Donald (October 2003). „Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases”. J. Biol. Chem.278 (41): 39609–14. DOI:10.1074/jbc.M305770200. PMID12893824.
Bai RY, Jahn T, Schrem S, Munzert G, Weidner K M, Wang J Y, Duyster J (August 1998). „The SH2-containing adapter protein GRB10 interacts with BCR-ABL”. Oncogene17 (8): 941–8. DOI:10.1038/sj.onc.1202024. PMID9747873.
Frantz JD, Giorgetti-Peraldi S, Ottinger E A, Shoelson S E (January 1997). „Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains”. J. Biol. Chem.272 (5): 2659–67. DOI:10.1074/jbc.272.5.2659. PMID9006901.
Kumar V, Sabatini D, Pandey P, Gingras A C, Majumder P K, Kumar M, Yuan Z M, Carmichael G, Weichselbaum R, Sonenberg N, Kufe D, Kharbanda S (April 2000). „Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase”. J. Biol. Chem.275 (15): 10779–87. DOI:10.1074/jbc.275.15.10779. PMID10753870.
Warmuth M, Bergmann M, Priess A, Häuslmann K, Emmerich B, Hallek M (December 1997). „The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr”. J. Biol. Chem.272 (52): 33260–70. DOI:10.1074/jbc.272.52.33260. PMID9407116.
Koch A, Mancini A, Stefan M, Niedenthal R, Niemann H, Tamura T (March 2000). „Direct interaction of nerve growth factor receptor, TrkA, with non-receptor tyrosine kinase, c-Abl, through the activation loop”. FEBS Lett.469 (1): 72–6. DOI:10.1016/S0014-5793(00)01242-4. PMID10708759.
Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang Y Y, Lu H, Kharbanda S, Weichselbaum R, Kufe D (June 1999). „p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage”. Nature399 (6738): 814–7. DOI:10.1038/21704. PMID10391251.
Agami R, Blandino G, Oren M, Shaul Y (June 1999). „Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis”. Nature399 (6738): 809–13. DOI:10.1038/21697. PMID10391250.
Cong F, Spencer S, Côté J F, Wu Y, Tremblay M L, Lasky L A, Goff S P (December 2000). „Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation”. Mol. Cell6 (6): 1413–23. DOI:10.1016/S1097-2765(00)00138-6. PMID11163214.
Miyamura T, Nishimura J, Yufu Y, Nawata H (February 1997). „Interaction of BCR-ABL with the retinoblastoma protein in Philadelphia chromosome-positive cell lines”. Int. J. Hematol.65 (2): 115–21. DOI:10.1016/S0925-5710(96)00539-7. PMID9071815.
Welch PJ, Wang J Y (November 1993). „A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle”. Cell75 (4): 779–90. DOI:10.1016/0092-8674(93)90497-E. PMID8242749.
Agami R, Shaul Y (April 1998). „The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes”. Oncogene16 (14): 1779–88. DOI:10.1038/sj.onc.1201708. PMID9583676.
Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, Geromanos S, Kavanaugh W M, Tempst P, Clarkson B (April 1999). „A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells”. Blood93 (8): 2707–20. PMID10194451.
Wang B, Golemis E A, Kruh G D (July 1997). „ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks”. J. Biol. Chem.272 (28): 17542–50. DOI:10.1074/jbc.272.28.17542. PMID9211900.
Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim K S, Jenkins E C, Trenkner E, Kotula L (May 1998). „Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton”. J. Biol. Chem.273 (22): 13681–92. DOI:10.1074/jbc.273.22.13681. PMID9593709.
Bassermann F, Jahn Thomas, Miething Cornelius, Seipel Petra, Bai Ren-Yuan, Coutinho Sunita, Tybulewicz Victor L, Peschel Christian, Duyster Justus (April 2002). „Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway”. J. Biol. Chem.277 (14): 12437–45. DOI:10.1074/jbc.M112397200. PMID11790798.
Rafalska I, Zhang Zhaiyi, Benderska Natalya, Wolff Horst, Hartmann Annette M, Brack-Werner Ruth, Stamm Stefan (August 2004). „The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation”. Hum. Mol. Genet.13 (15): 1535–49. DOI:10.1093/hmg/ddh167. PMID15175272.
Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M (June 2008). „Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression”. Cancer Cell13 (6): 496–506. DOI:10.1016/j.ccr.2008.04.018. PMID18538733.
